Detection of Chlamydia pneumoniae in cholesteatoma tissue: Any pathogenetic role?

Otology and Neurotology

Volumn 24, Issue 3, 2003, Pages 353-357

  Ronchetti, Francesco ^a   Ronchetti, Roberto ^a   Guglielmi, Francesco ^a   Chiappini, Ilaria ^a   Contini, Carlo ^b   Filipo, Roberto ^a   Santino, Iolanda ^a   Cerruto, Rosario ^a   Bernardeschi, Daniele ^a   Barbara, Maurizio ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; CHILD; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; CLINICAL ARTICLE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; IMMUNE STATUS; MALE; MYCOPLASMA PNEUMONIAE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BLOTTING, SOUTHERN; CHEMILUMINESCENT MEASUREMENTS; CHILD; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEATOMA, MIDDLE EAR; DNA PRIMERS; DNA, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 0038813828     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200305000-00001     Document Type: Article

References (44)

1. Tos M. Incidence, etiology and pathogenesis of cholesteatoma in children. Otol Rhinol Laryngol 1988;40:110-7.
2. Byron J, Bailey J. Head Neck Surgery-Otolaryngology. Philadelphia: Lippincott, 1993.
3. Vennix PCA, Kuijpers W, Peters T, et al. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes. Arch Otolaryngol Head Neck Surg 1996;122:825-32.
4. Vartiainen E, Vartiainen J. Effect of aerobic bacteriology on the clinical presentation and treatment results of chronic suppurative otitis media. J Laryngol Otol 1996;110:315-8.
5. Kemppainen HO, Puhakka HJ, Laippala PJ, et al. Epidemiology and etiology of middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1999;119:568-72.
6. Melon J, Goret F. La microbiologie du cholesteatome. Acta Otorhinolaryngol Belg 1980;34:1.
7. Fliss DM, Meidan N, Dagan R, Leiberman A. Aerobic bacteriology of chronic suppurative otitis media without cholesteatoma in children. Ann Otol Rhinol Laryngol 1992;101:866-9.
8. Brook I. Role of anaerobic bacteria in chronic otitis media and cholesteatoma. Int J Pediatr Otorhinolaryngol 1995;31:153-7.
9. Black PN, Scicchitano R, Jenkins CR, et al. Serological evidence of infection with C. pneumoniae is related to the severity of asthma. Eur Respir J 2000;15:254-9.
10. Rosenfeld M, Blessing E, Lin TM, et al. Chlamydia, inflammation, and atherogenesis. J Infect Dis 2000;181(Suppl 3):S492-7.
11. Esposito G, Blasi F, Allegra L, et al. Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotic arteries by reverse transcription polymerase chain reaction. Ann Vasc Surg 1999;13:421-5.
12. Balin BJ, Gerard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (Berl) 1998;187:23-42.
13. Held TK, Biell SS, Nitsche A, et al. Treatment of BK virusassociated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000;25:1257-62.
14. Van Ketel RJ, Ter Schegget J, Zanen HC. Molecular epidemiology of Legionella pneumophila serogroup 1. J Clin Microbiol 1984:20;362-4.
15. Kellog DE, Kwok S. Detection of human immunodeficiency virus. In: Innis MA. Gelfand DH. Sniniky JJ. White TJ, eds. PCR Protocols: A Guide to Methods and Applications. San Diego: Academic Press, 1990:337-47.
16. Don RH, Cox PT, Wainwright BJ, et al. "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucl Acid Res 1991;19:4008.
17. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998;11:345-49.
18. Gaydos CA, Fowler CL, Gill VJ, et al. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population. Clin Infect Dis 1993;17:718-23.
19. Mahony JB, Chong S, Coombs BK, et al. Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells. J Clin Microbiol 2000;38:2622-7.
20. Kroll JS, Hopkins I, Moxon ER. Capsule loss in H. influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export. Cell 1988;43:347-56.
21. Deich RA, Metcalf BJ, Finn CW, et al. Cloning of genes encoding a 15000-dalton peptidoglycan-associated outer membrane lipoprotein and an antigenically related 15000-dalton protein from H. influenzae. J Bacteriol 1988;170:489-98.
22. Chen R, Henning U. Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of E. coli K12. Eur J Biochem 1987;163:73-7.
23. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
24. Roulland-Dussoix D, Henry A, Lemercier D. Detection of Mycoplasmas in cell cultures by PCR: a one year study. J Microbial Methods 1994;19:127-34.
25. Blanchard A, Hentschel J, Duffy L, et al. Detection Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid and in the respiratory tract of newborns. Clin Infect Dis. 1993;17(Suppl 1):S148-S53.
26. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr 2001;160:407-13.
27. Kauppinen MT, Saikku P, Kujala P, et al. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between Chlamydial and pneumococcal pneumonia. Thorax 1996;51:185-9.
28. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000;16:1142-6.
29. Marrie TJ. Chlamydia pneumoniae. Thorax 1993;48:1-4.
30. Zhang JP, Stephens RS. Mechanism of C. trachomatis attachment to eucaryotic host cell. Cell 1992;69:861-69.
31. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult onset asthma. JAMA 1991;266:225-30.
32. von Hertzen L, Leinonen M, Koskinen R, et al. Evidence of persistent Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. In: Orfila J, Byrne GI. Proceeding of the Eight International Symposium on Human Chlamydial Infections. Bologna, Italy: Società Editrice Esculapio, 473-6.
33. Surcel HM, Syrjala H, Leinonen M, et al. Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocytes blast transformation in vitro. Infect Immunol 1993;61:2196-9.
34. Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, et al. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 1999;162:2829-36.
35. Wahlstrom J, Dahlen B, Ihre E, et al. Selective CD8+ T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation. Clin Exp Immunol 1998;112:1-9.
36. Peters BS, Thomas B, Marshall B, et al. The role of Chlamydia pneumoniae in acute exacerbation of asthma. Am J Respir Crit Care Med 1994;149:34A.
37. Rosenfeld ME, Blessing E, Lin TM, et al. Chlamydia, inflammation and atherogenesis. J Infect Dis 2000;181(Suppl 3): S492-7.
38. Byrne GI, Skarlotos SI, Grunfeld C, et al. Collaborative multidisciplinary workshop report: interface of lipid metabolism, atherosclerosis and Chlamydia infection. J Infect Dis 2000;181(Suppl 3):S490-1.
39. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of C. pneumoniae TWAR in human coronary arterectomy tissues. J Infect Dis 1995;172:585-8.
40. Thom DH, Grayston JT, Siscovick DS, et al. Association or prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
41. Gaydos CA. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 2000;181(Suppl 3):S473-8.
42. Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur Heart J 1993;14(Suppl K):2-6.
43. Gerard HC, Wang GF, Balin BJ, et al. Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides. Microb Pathog 1999;26:35-43.
44. Lundemose JB, Lundemose GA, Gregersen M, et al. Chlamydia and sudden infant death syndrome: a study of 166 SIDS and 30 control cases Int J Leg Med 1990;104:3-7.